I’d say you must be right. The FDA were so impressed with the...

I’d say you must be right.

The FDA were so impressed with the results they were in a state of shock and ticked the ‘approval rejected’ box instead of the “approved” box on msb’s application form.

Big pharma (loads of them) are also in a stupor and despite being shopped around the traps, no one wants to even partner let alone buy the IP over the course of many years.

I mean, here we are, with all these applications for an alleged paradigm advancement in medical treatment for a wide range of conditions but no one will touch the product.

Simply bizarre. I don’t understand that. When it’s fairly routine for promising treatments to be snapped up by big pharma well before final approvals… sometimes quite early in the development.